What was the market valuation for lymphedema treatment in South Korea in 2024?

The market valuation for lymphedema treatment in South Korea was $11.75 Million in 2024. Read More

What is the projected market valuation for lymphedema treatment in South Korea by 2035?

The projected market valuation for lymphedema treatment in South Korea is $30.89 Million by 2035. Read More

What is the expected CAGR for the South Korea lymphedema treatment market during the forecast period 2025 - 2035?

The expected CAGR for the South Korea lymphedema treatment market during the forecast period 2025 - 2035 is 9.18%. Read More

Which segment had the highest valuation in the South Korea lymphedema treatment market in 2024?

In 2024, the segment for Secondary Lymphedema had the highest valuation at $19.39 Million. Read More

Which area of the body is most affected by lymphedema in South Korea?

The Lower Extremity is the most affected area, with a valuation of $14.5 Million projected for 2035. Read More

Who are the leading players in the South Korea lymphedema treatment market?

Leading players include Medi USA, BSN Medical, Tactile Medical, and Sigvaris, among others. Read More

What is the projected valuation for the Compression Devices & Bandaging segment by 2035?

The projected valuation for the Compression Devices & Bandaging segment is $11.5 Million by 2035. Read More

How does the market for lymphedema treatment in South Korea compare between hospitals and clinics versus research institutes?

In 2024, hospitals and clinics had a valuation of $14.3 Million, compared to $8.49 Million for research and academic institutes. Read More

What is the expected growth trend for the Upper Extremity segment in the South Korea lymphedema treatment market?

The Upper Extremity segment is expected to grow, with a projected valuation of $8.0 Million by 2035. Read More

South Korea Lymphedema Treatment Market

Q: What are the key treatment types in the South Korea lymphedema treatment market?

Key treatment types include Compression Devices & Bandaging, Laser Therapy, Drug Therapy, and Surgery. Read More

ID: MRFR/HC/49232-HCR

200 Pages

Rahul Gotadki

Last Updated: February 06, 2026

South Korea Lymphedema Treatment Market Research Report: Size, Share, Trend Analysis By Types (Primary Lymphedema, Secondary Lymphedema), By Affected Area (Lower Extremity, Upper Extremity, Genitalia), By Treatment (Compression Devices & Bandaging, Laser Therapy, Drug Therapy & Surgery) andBy End-User (Hospitals and Clinics, Clinical Research Organizations, Research & Academic Institutes) - Growth Outlook & Industry Forecast 2025 To 2035

South Korea Lymphedema Treatment Market

Market Size

Forecast Period2025 - 2035

CAGR (2025 - 2035)9.18%

2024 Market Size$ 11.75 Million

2025 Market Size$ 12.83 Million

2035 Market Size$ 30.89 Million

Key Players

Medi USA

BSN Medical

Tactile Medical

Lympha Press

Sigvaris

Juzo

Trends

Rising Awareness and Education
Advancements in Treatment Technologies
Integration of Multidisciplinary Care Approaches

Opportunities

Government Initiatives and Funding
Increasing Incidence of Lymphedema
Technological Innovations in Treatment

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Pharmaceutical, BY Type (USD Million)
  1. 4.1.1 Primary Lymphedema
  2. 4.1.2 Secondary Lymphedema
2. 4.2 Pharmaceutical, BY Affected Area (USD Million)
  1. 4.2.1 Lower Extremity
  2. 4.2.2 Upper Extremity
  3. 4.2.3 Genitalia
3. 4.3 Pharmaceutical, BY Treatment (USD Million)
  1. 4.3.1 Compression Devices & Bandaging
  2. 4.3.2 Laser Therapy
  3. 4.3.3 Drug Therapy
  4. 4.3.4 Surgery
4. 4.4 Pharmaceutical, BY End-User (USD Million)
  1. 4.4.1 Hospitals and Clinics
  2. 4.4.2 Clinical Research Organizations
  3. 4.4.3 Research & Academic Institutes
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Pharmaceutical
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Pharmaceutical
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Medi USA (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 BSN Medical (DE)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Tactile Medical (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Lympha Press (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Sigvaris (CH)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Juzo (DE)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Essity (SE)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 3M (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Kangjie (CN)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 SOUTH KOREA MARKET ANALYSIS BY TYPE
3. 6.3 SOUTH KOREA MARKET ANALYSIS BY AFFECTED AREA
4. 6.4 SOUTH KOREA MARKET ANALYSIS BY TREATMENT
5. 6.5 SOUTH KOREA MARKET ANALYSIS BY END-USER
6. 6.6 KEY BUYING CRITERIA OF PHARMACEUTICAL
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF PHARMACEUTICAL
9. 6.9 DRIVERS IMPACT ANALYSIS: PHARMACEUTICAL
10. 6.10 RESTRAINTS IMPACT ANALYSIS: PHARMACEUTICAL
11. 6.11 SUPPLY / VALUE CHAIN: PHARMACEUTICAL
12. 6.12 PHARMACEUTICAL, BY TYPE, 2024 (% SHARE)
13. 6.13 PHARMACEUTICAL, BY TYPE, 2024 TO 2035 (USD Million)
14. 6.14 PHARMACEUTICAL, BY AFFECTED AREA, 2024 (% SHARE)
15. 6.15 PHARMACEUTICAL, BY AFFECTED AREA, 2024 TO 2035 (USD Million)
16. 6.16 PHARMACEUTICAL, BY TREATMENT, 2024 (% SHARE)
17. 6.17 PHARMACEUTICAL, BY TREATMENT, 2024 TO 2035 (USD Million)
18. 6.18 PHARMACEUTICAL, BY END-USER, 2024 (% SHARE)
19. 6.19 PHARMACEUTICAL, BY END-USER, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 South Korea MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY TYPE, 2025-2035 (USD Million)
  2. 7.2.2 BY AFFECTED AREA, 2025-2035 (USD Million)
  3. 7.2.3 BY TREATMENT, 2025-2035 (USD Million)
  4. 7.2.4 BY END-USER, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

South Korea Pharmaceutical Market Segmentation

Pharmaceutical By Type (USD Million, 2025-2035)

Primary Lymphedema
Secondary Lymphedema

Pharmaceutical By Affected Area (USD Million, 2025-2035)

Lower Extremity
Upper Extremity
Genitalia

Pharmaceutical By Treatment (USD Million, 2025-2035)

Compression Devices & Bandaging
Laser Therapy
Drug Therapy
Surgery

Pharmaceutical By End-User (USD Million, 2025-2035)

Hospitals and Clinics
Clinical Research Organizations
Research & Academic Institutes

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”